ATORVALIQ
- Strength
- 20 mg/5mL
- Form
- Suspension
- Class
- HMG-CoA Reductase Inhibitor
CMP Pharma, Inc.
Listed by Cipla USA Inc.,
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | HMG-CoA Reductase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 69097-899 |
| FDA application | ANDA205519 |
| RxNorm concept | 259255 |
| Package sizes listed | 2 |
| Marketed since | August 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
CMP Pharma, Inc.
Bryant Ranch Prepack
DIRECT RX
Novadoz Pharmaceuticals LLC
Radha Pharmaceuticals, Inc.
Camber Pharmaceuticals, Inc.
Macleods Pharmaceuticals Limited
Laurus Labs Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.